Standard BioTools Inc. (LAB)
NASDAQ: LAB
· Real-Time Price · USD
1.10
0.05 (4.76%)
At close: Jun 16, 2025, 3:59 PM
1.10
-0.13%
After-hours: Jun 16, 2025, 05:15 PM EDT
4.76% (1D)
| Bid | 1.03 |
| Market Cap | 417.8M |
| Revenue (ttm) | 169.69M |
| Net Income (ttm) | -132.76M |
| EPS (ttm) | -0.32 |
| PE Ratio (ttm) | -3.44 |
| Forward PE | -7.07 |
| Analyst | Hold |
| Ask | 1.18 |
| Volume | 513,840 |
| Avg. Volume (20D) | 1,288,736 |
| Open | 1.07 |
| Previous Close | 1.05 |
| Day's Range | 1.04 - 1.10 |
| 52-Week Range | 0.92 - 2.41 |
| Beta | 1.50 |
Analyst Forecast
According to 0 analyst ratings, the average rating for LAB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-3.77%
LAB stock has given up its prior gain. Standard Bi...
Unlock content with
Pro Subscription
1 month ago
-3.77%
Standard BioTools shares are trading higher after the company reported better-than-expected Q1 sales results.
1 month ago · seekingalpha.com
Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call TranscriptStandard BioTools Inc. (NASDAQ:LAB ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants John Graziano - VP of IR Michael Egholm - President & CEO Alex Kim - CFO Conference Ca...
